SEC Form 4 · accession 0001387131-17-005543
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Cannon
Director
Period of report
Nov 10, 2017
Accepted (ET)
Nov 14, 2017 · 9:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 10, 2017 | P | 17,801 | $0.8211 | A | 44,801 | D | |
| Common StockF2 | Nov 13, 2017 | P | 6,000 | $0.79 | A | 50,801 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $0.7388 to $0.9041, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2Shares held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon.